CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varma, T. K.
Right arrow Articles by Sherwood, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varma, T. K.
Right arrow Articles by Sherwood, E. R.
Clinical and Diagnostic Laboratory Immunology, May 2002, p. 530-543, Vol. 9, No. 3
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.3.530-543.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Endotoxin-Induced Gamma Interferon Production: Contributing Cell Types and Key Regulatory Factors

Tushar K. Varma,1 Cheng Y. Lin,1 Tracy E. Toliver-Kinsky,1,2 and Edward R. Sherwood1,2*

Department of Anesthesiology, The University of Texas Medical Branch,1 The Shriner's Hospital for Children-Galveston Burns Unit, Galveston, Texas2

Received 30 July 2001/ Returned for modification 5 October 2001/ Accepted 2 January 2002

Gamma interferon (IFN-{gamma}) is an important mediator of endotoxin (lipopolysaccharide [LPS])-induced immune responses. However, the specific cell types that produce IFN-{gamma} in response to LPS and the cellular factors that regulate LPS-induced IFN-{gamma} production have not been fully determined. The present studies were undertaken to characterize the cell populations that produce IFN-{gamma} after LPS challenge in the spleens of mice and to determine the regulatory factors that modulate LPS-induced production of IFN-{gamma}. Our studies show that the levels of splenic IFN-{gamma} mRNA and protein production peak at 6 and 8 h, respectively, after systemic LPS challenge. Approximately 60% of IFN-{gamma}-producing cells are natural killer (NK) cells (CD3-DX5+) and 25% are NKT cells (CD3+DX5+). Most of the remaining IFN-{gamma}-producing cells are T cells (CD3+DX5-), macrophages, and dendritic cells. Functionally, interleukin-12 (IL-12) is the major IFN-{gamma}-stimulating factor after LPS challenge, with costimulation provided by IL-15, IL-18, and B7 proteins. IL-10 is a major inhibitor of LPS-induced IFN-{gamma} production. Unlike intact heat-killed gram-negative and gram-positive bacteria, the class II major histocompatibility complex did not play a functional role in LPS-induced IFN-{gamma} production. LPS is a potent stimulus for splenic IL-10, IL-12 p40, and IL-15 mRNA expression, whereas IL-12 p35 and IL-18 mRNAs, as well as B7 proteins, are constitutively expressed in the mouse spleen. Of the factors studied, IL-18 serves as the most potent costimulus with IL-12 for IFN-{gamma} production, followed by IL-15 and B7 proteins. These data demonstrate that NK cells and NKT cells are the most abundant IFN-{gamma}-producing cells in the mouse spleen after LPS challenge and that IL-10 and IL-12 are key functional regulators of LPS-induced IFN-{gamma} production.


* Corresponding author. Mailing address: Department of Anesthesiology, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-0591. Phone: (409) 772-1221. Fax: (409) 772-1224. E-mail: ERSherwo{at}UTMB.edu.


Clinical and Diagnostic Laboratory Immunology, May 2002, p. 530-543, Vol. 9, No. 3
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.3.530-543.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.